| 发明名称 |
Use of HIV protease inhibiting compounds |
| 摘要 |
The invention relates to the use of at least one compound that inhibits HIV (human immunodeficiency virus) protease, selected from ritonavir, saquinavir or one of the pharmaceutically acceptable salts thereof, in association with a pharmaceutically acceptable vehicle for the production of a medicament to modulate proteasome.
|
| 申请公布号 |
US6506555(B1) |
申请公布日期 |
2003.01.14 |
| 申请号 |
US20010719140 |
申请日期 |
2001.06.19 |
| 申请人 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);BIOMERIEUX |
发明人 |
ANDRE PATRICE;LOTTEAU VINCENT;KLENERMAN PAUL;ZINKERNAGEL ROLF;GROETTRUP MARCUS |
| 分类号 |
A61K31/426;A61K31/427;A61K31/4725;A61P3/10;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P31/12;A61P31/18;A61P35/00;A61P37/02;A61P37/06;A61P43/00;(IPC1-7):C12Q1/70;A61K39/12;A01N43/58 |
主分类号 |
A61K31/426 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
